HEPATOCEREBRAL FORM OF MDS. DIAGNOSTIC DIFFICULTIES

被引:0
|
作者
Tsygankova, P. G. [1 ]
Zakharova, E. Yu [1 ]
Nikolaeva, E. A. [2 ]
Degtyareva, A., V [3 ]
Itkis, Y. S. [1 ]
机构
[1] Russian Acad Med Sci, Med Genet Res Ctr, Moscow, Russia
[2] Ins Pediatr Child Surg, Moscow, Russia
[3] Rus Med Inst, Moscow, Russia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S169 / S169
页数:1
相关论文
共 50 条
  • [21] A patient-reported outcome measure for symptoms of AML/MDS.
    Williams, Loretta A.
    Garcia-Gonzalez, Araceli
    Ahaneku, Hycienth
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Shi, Qiuling
    Borthakur, Gautam
    Burger, Jan Andreas
    Jabbour, Elias
    Takahashi, Koichi
    Lin, Huei-Kai
    Limaye, Achala
    Cleeland, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Clinical and laboratory analysis of differentiating effects of ethyol treatment in MDS.
    Pfeilstocker, M
    Mostl, M
    Karlic, H
    Gruner, H
    Reisner, R
    Nosslinger, T
    Tuchler, H
    Waldner, R
    Pittermann, E
    BLOOD, 2001, 98 (11) : 273B - 273B
  • [23] Effect of erythropoietin on platelet function and glycoprotein expression in patients with MDS.
    Girtovitis, FFI
    Bougiouklis, DD
    Makris, MMP
    Pithara, EE
    Makris, PPE
    BLOOD, 2005, 106 (11) : 78B - 78B
  • [24] Impact of genetic polymorphisms on immune response and clinical features in MDS.
    Serio, Bianca
    Jankowska, Anna
    Ramsingh, Giridharan
    Nearman, Zach
    Szpurka, Hadrian
    Tiu, Ramon
    O'Keefe, Christine
    Sekeres, Mikkael A.
    Maciejewski, Jaroslaw P.
    BLOOD, 2006, 108 (11) : 755A - 755A
  • [25] Combined chemotherapy for patients with high risk myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS.
    Shi, J
    Shao, ZH
    Liu, H
    Chen, GB
    Zhang, YZ
    Bai, J
    He, GS
    Fu, R
    Zhao, MF
    Cao, YR
    Wu, YH
    Jing, LP
    Hao, YS
    Yang, TY
    BLOOD, 2003, 102 (11) : 13B - 13B
  • [26] A Cross-Disciplinary Study of What Determines the Adoption of MDS.
    Shi, Cong Kristy
    Hao, Xiaoming
    Sharma, Ravi S.
    43RD HAWAII INTERNATIONAL CONFERENCE ON SYSTEMS SCIENCES VOLS 1-5 (HICSS 2010), 2010, : 1179 - 1189
  • [27] Hepatocerebral form of mitochondrial DNA depletion syndrome
    Spinazzola, Antonella
    Santer, Rene
    Akman, Orhan H.
    Tsiakas, Kostas
    Schaefer, Hansjoerg
    Ding, Xiaoqi
    Karadimas, Charalampos L.
    Shanske, Sara
    Ganesh, Jaya
    Di Mauro, Salvatore
    Zeviani, Massimo
    ARCHIVES OF NEUROLOGY, 2008, 65 (08) : 1108 - 1113
  • [28] Diagnostic Difficulties Reveal Rare form of Membranous Esophageal Atresia
    Beltran Arasa, Eva
    Vetter-Laracy, Susanne
    Benitez-Segura, Ignacio
    Moreno Montero, Ana
    Marhuenda Irastorza, Claudia
    Balliu Badia, Pere Ramon
    KLINISCHE PADIATRIE, 2020, 232 (01): : 33 - 34
  • [29] Prognostic Impact of Multiparameter Flow Cytometry in Patients Analyzed for Suspected MDS.
    Kern, Wolfgang
    Haferlach, Claudia
    Alpermann, Tamara
    Schnittger, Susanne
    Haferlach, Torsten
    BLOOD, 2012, 120 (21)
  • [30] Correlation of patient prognosis with PU.1 and JDP2 to provide potential novel prognostic/diagnostic markers in MDS.
    Simpson, Rachael
    Goddard, Alan
    Lally, James
    Simmonds, Matthew
    Rinaldi, Ciro Roberto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35